AllianceBernstein
LFCR icon

AllianceBernstein’s Lifecore Biomedical LFCR Stock Holding History

AllianceBernstein’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,500
Closed -$77.4K – 3209
2023
Q1 		$77.4K Buy
20,500
+1,100
+6% +$6.13K ﹤0.01% 3050
2022
Q4 		$126K Buy
19,400
+700
+4% +$5.77K ﹤0.01% 3091
2022
Q3 		$166K Buy
18,700
+600
+3% +$6.1K ﹤0.01% 3054
2022
Q2 		$180K Hold
18,100
– – ﹤0.01% 3044
2022
Q1 		$210K Buy
18,100
+100
+0.6% +$1.11K ﹤0.01% 2982
2021
Q4 		$200K Sell
18,000
-1,300
-7% -$12.6K ﹤0.01% 3075
2021
Q3 		$178K Sell
19,300
-900
-4% -$9.79K ﹤0.01% 3108
2021
Q2 		$227K Sell
20,200
-3,700
-15% -$42.7K ﹤0.01% 3120
2021
Q1 		$253K Sell
23,900
-7,900
-25% -$88.8K ﹤0.01% 2972
2020
Q4 		$345K Sell
31,800
-10,701
-25% -$111K ﹤0.01% 2788
2020
Q3 		$413K Sell
42,501
-859
-2% -$8.18K ﹤0.01% 2630
2020
Q2 		$345K Buy
43,360
+14,060
+48% +$145K ﹤0.01% 2819
2020
Q1 		$255K Buy
29,300
+2,500
+9% +$26K ﹤0.01% 2699
2019
Q4 		$303K Hold
26,800
– – ﹤0.01% 2772
2019
Q3 		$291K Buy
26,800
+2,800
+12% +$30.5K ﹤0.01% 2815
2019
Q2 		$225K Buy
24,000
+3,815
+19% +$38.5K ﹤0.01% 2926
2019
Q1 		$248K Buy
20,185
+2,485
+14% +$30.3K ﹤0.01% 2832
2018
Q4 		$210K Buy
17,700
+900
+5% +$12.4K ﹤0.01% 2872
2018
Q3 		$242K Hold
16,800
– – ﹤0.01% 2924
2018
Q2 		$250K Sell
16,800
-500
-3% -$6.95K ﹤0.01% 2878
2018
Q1 		$226K Buy
17,300
+1,600
+10% +$21K ﹤0.01% 2800
2017
Q4 		$198K Sell
15,700
-500
-3% -$6.32K ﹤0.01% 2874
2017
Q3 		$210K Hold
16,200
– – ﹤0.01% 2915
2017
Q2 		$241K Buy
+16,200
New +$226K ﹤0.01% 2910
2015
Q2 		– Sell
-5,800
Closed -$81K – 3158
2015
Q1 		$81K Sell
5,800
-700
-11% -$9.67K ﹤0.01% 3052
2014
Q4 		$90K Sell
6,500
-1,800
-22% -$23.3K ﹤0.01% 3009
2014
Q3 		$102K Sell
8,300
-5,100
-38% -$63.7K ﹤0.01% 2962
2014
Q2 		$167K Sell
13,400
-7,145
-35% -$84.1K ﹤0.01% 2867
2014
Q1 		$229K Sell
20,545
-2,900
-12% -$31.8K ﹤0.01% 2718
2013
Q4 		$284K Sell
23,445
-5,200
-18% -$62.1K ﹤0.01% 2684
2013
Q3 		$349K Sell
28,645
-70
-0.2% -$977 ﹤0.01% 2657
2013
Q2 		$379K Buy
+28,715
New +$397K ﹤0.01% 2621

Other funds holding LFCR

GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

AllianceBernstein's LFCR Position: Q2 2023 in Review

AllianceBernstein sold out of Lifecore Biomedical (LFCR) in Q2 2023, closing a stake of 20,500 shares — an estimated $77.4K sold.

AllianceBernstein first reported a position in LFCR in Q2 2013 and held it in 32 quarters. The position peaked at $413K in Q3 2020. 75 funds tracked by Wall St. Rank hold LFCR as of Q2 2023.

  • AllianceBernstein reported no remaining Lifecore Biomedical position as of Q2 2023 after selling out during the quarter.
  • AllianceBernstein sold 20,500 Lifecore Biomedical shares in Q2 2023, an estimated $77.4K.
  • AllianceBernstein first reported a position in Lifecore Biomedical in Q2 2013 and held it in 32 quarters.
  • AllianceBernstein's Lifecore Biomedical position peaked at $413K in Q3 2020.
  • 75 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2023.

Based on AllianceBernstein's 13F filing for Q2 2023, filed 15 Aug 2023.